NEW YORK, June 7, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Reata Pharmaceuticals, Inc.: On May 10, 2023, Reata issued a press release announcing its financial results for the first quarter of 2023. Among other items, Reata announced its…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.